| Flufenamic acid | IC50 | 530.0 [1] |
| Indomethacin | IC50 | 36530.0 [1], 75000.0 [2], 100000.0 [3] |
| Indomethacin | Ki | 100000.0 [1] |
| N-Phenylanthranilic acid | IC50 | 440.0 [1] |
| 4-(Phenylamino)benzoic acid | IC50 | 3000.0 [1] |
| 3-((4-(Trifluoromethyl)Phenyl)Amino)Benzoic Acid | IC50 | 15000.0 [1], 15400.0 [2] |
| 3-[(4-Nitrophenyl)amino]benzoic Acid | IC50 | 3380.0 [1], 3400.0 [2] |
| 3-(4-Acetylanilino)benzoic acid | IC50 | 19000.0 [1], 19500.0 [2] |
| 3-((4-Methoxyphenyl)amino)benzoic acid | IC50 | 11000.0 [1], 11500.0 [2] |
| 3-(Phenylamino)benzoic acid | IC50 | 12900.0 [1], 13000.0 [2] |
| 3-[(4-Bromophenyl)Amino]Benzoic Acid | IC50 | 18000.0 [1], 18100.0 [2] |
| 3-(4-Tert-butylanilino)benzoic acid | IC50 | 31000.0 [1], 31100.0 [2] |
| 3-[(4-Methylphenyl)Amino]Benzoic Acid | IC50 | 56000.0 [1], 56200.0 [2] |
| 3-[(4-Chlorophenyl)Amino]Benzoic Acid | IC50 | 19000.0 [1], 19100.0 [2] |
| Medroxyprogesterone acetate | IC50 | 1600.0 [1], 4100.0 [2] |
| Jasmonic acid | Ki | 15000.0 [1], 18000.0 [2] |
| Mefenamic acid | IC50 | 6970.0 [1] |
| Mefenamic acid | Ki | 220.0 [1] |
| Meclofenamic acid | IC50 | 8740.0 [1] |
| 3,5-Dichlorosalicylic acid | Ki | 70.0 [1] |
| 5-Bromo-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid | Ki | 87.0 [1] |
| 1-(4-Chlorobenzoyl)-5-methoxy-1H-indole-3-acetic acid | IC50 | 100.0 [1], 100000.0 [2] |
| 1-[4-(3,4-Dihydro-1H-isoquinolin-2-ylsulfonyl)phenyl]pyrrolidin-2-one | IC50 | 30000.0 [1] |
| 3-[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]propanoic acid | IC50 | 57.0 [1], 56530.0 [2] |
| 2-[5-Methoxy-2-methyl-1-(4-methylbenzoyl)indol-3-yl]acetic acid | IC50 | 54.5 [1], 54500.0 [2] |
| 5-Hydroxy-3-[(4-methoxyphenyl)methyl]-N-[3-(trifluoromethyl)phenyl]triazole-4-carboxamide | IC50 | 73230.0 [1] |
| 9-(4-Chlorobenzoyl)-6-methoxy-1,2,3,4-tetrahydrocarbazole-3-carboxylic acid | IC50 | 53.5 [1], 53650.0 [2] |
| 3a-Phenyl-3,4-dihydro-2H-pyrrolo[1,2-a]benzimidazol-1-one | IC50 | 92300.0 [1] |
| 3a-Phenyl-3,4-dihydro-2H-pyrrolo[1,2-a]benzimidazol-1-one | Ki | 46200.0 [1] |
| 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-N-(trifluoromethylsulfonyl)acetamide | IC50 | 81.0 [1], 80950.0 [2] |
| 1h-Indole-3-acetic acid,5-methoxy-2-methyl-1-[4-(trifluoromethyl)benzoyl]- | IC50 | 35.73 [1], 35730.0 [2] |
| 2-(2,4-Dioxo-1,3-thiazolidin-5-yl)-N-(2-hydroxyphenyl)acetamide | IC50 | 205700.0 [1] |
| 2-(2,4-Dioxo-1,3-thiazolidin-5-yl)-N-(2-hydroxyphenyl)acetamide | Ki | 102800.0 [1] |
| 3-[1-(4-Chlorobenzoyl)-5-methoxy-3-methylindol-2-yl]propanoic acid | IC50 | 14.5 [1], 14450.0 [2] |
| 3-[1-(4-Chlorobenzoyl)-5-methoxy-3-methylindol-2-yl]-N-methylsulfonylpropanamide | IC50 | 93.0 [1], 93000.0 [2] |
| 3-[1-(4-Chlorobenzoyl)-3-ethyl-5-methoxyindol-2-yl]propanoic acid | IC50 | 49.57 [1], 49570.0 [2] |
| 2-[1-(4-Chlorobenzoyl)-5-methoxyindol-3-yl]-N-(trifluoromethylsulfonyl)acetamide | IC50 | 50.13 [1], 50130.0 [2] |
| 1-[4-(Chloromethyl)benzoyl]-2-methyl-5-methoxy-1H-indole-3-acetic acid | IC50 | 40.74 [1], 40740.0 [2] |
| Diazepam | IC50 | 2400.0 [1] |
| Naproxen | IC50 | 31300.0 [1] |
| Flurbiprofen | IC50 | 32500.0 [1] |
| Caffeic acid phenethyl ester | IC50 | 6000.0 [1] |
| Dexibuprofen | IC50 | 42400.0 [1] |
| 5-Methoxy-2-methyl-3-indoleacetic acid | IC50 | 100000.0 [1] |
| Cloxazolam | Ki | 10000.0 [1] |
| 2'-Hydroxyflavone | IC50 | 47100.0 [1] |
| 3,5-Dibromosalicylic acid | Ki | 82.0 [1] |
| (E)-3-(4-Hydroxy-3-(3-methyl-2-butenyl)phenyl)-2-propenoic acid | IC50 | 108000.0 [1] |
| 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acid | IC50 | 30000.0 [1] |
| 2-((4-Methoxyphenyl)amino)benzoic acid | IC50 | 700.0 [1] |
| 1-[4-(Piperidine-1-sulfonyl)-phenyl]-pyrrolidin-2-one | IC50 | 30000.0 [1] |
| N-[(2,6-Dioxo-4-phenylcyclohexylidene)methyl]glycine | Ki | 18200.0 [1] |
| 3-[(2-Naphthylsulfonyl)amino]propanoic acid | Ki | 57300.0 [1] |
| Morpholin-4-yl-(4-phenyl-piperazin-1-yl)-methanone | IC50 | 30000.0 [1] |
| Anthranilic acid, N-(3-methoxyphenyl)- | IC50 | 1110.0 [1] |
| Anthranilic acid, N-p-nitrophenyl- | IC50 | 280.0 [1] |
| 3-[(2-Phenylethyl)sulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-(1,3-Dihydro-isoindole-2-sulfonyl)-benzoic acid | IC50 | 30000.0 [1] |
| 4-[Methyl(phenylsulfonyl)amino]benzoic acid | Ki | 119000.0 [1] |
| 4-((3,4-Dihydroisoquinolin-2(1H)-yl)sulfonyl)benzoic acid | IC50 | 30000.0 [1] |
| 4-(4-Chlorophenyl)piperazinyl piperidyl ketone | IC50 | 30000.0 [1] |
| 7-Benzoyl-4,5-dihydro-1,4-benzoxazepin-3(2H)-one | Ki | 137000.0 [1] |
| 3-(2-Carboxyethylamino)naphthalene-2-carboxylic acid | Ki | 33000.0 [1] |
| [4-(4-Fluoro-phenyl)-piperazin-1-yl]-morpholin-4-yl-methanone | IC50 | 30000.0 [1] |
| 5-Chloro-4-Hydroxybiphenyl-3-Carboxylic Acid | Ki | 21.0 [1] |
| N-(3-Carboxyphenyl)anthranilic acid | IC50 | 4160.0 [1] |
| (E)-3-[3-(3-Methylbut-2-enyl)-4-(3-phenylpropanoyloxy)phenyl]prop-2-enoic acid | IC50 | 100000.0 [1] |
| 2-[(4-Methylphenyl)amino]benzoic acid | IC50 | 1460.0 [1] |
| Methyl 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate | IC50 | 100000.0 [1] |
| 1-{4-[(2-Methylpiperidin-1-yl)sulfonyl]phenyl}pyrrolidin-2-one | IC50 | 30000.0 [1] |
| N-(3-Methylphenyl)anthranilic acid | IC50 | 380.0 [1] |
| [4-(4-Chlorophenyl)piperazin-1-yl](morpholin-4-yl)methanone | IC50 | 30000.0 [1] |
| [1-(4-Fluorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid | IC50 | 60970.0 [1] |
| 3-(3,4-Dihydroisoquinolin-2(1h)-Ylsulfonyl)-N-Methylbenzamide | IC50 | 30000.0 [1] |
| 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-N-methylsulfonylacetamide | IC50 | 65390.0 [1] |
| 1-(4-Bromophenyl)sulfonylindole-3-carboxylic acid | IC50 | 30000.0 [1] |
| N-(2-Methoxyphenyl)anthranilic acid | IC50 | 1280.0 [1] |
| 1-Naphthalen-2-ylsulfonylpyrrolidine-3-carboxylic acid | IC50 | 30000.0 [1] |
| 5-Bromo-3-phenylsalicylic acid | Ki | 1970.0 [1] |
| 3-(3,4-Dihydro-2H-quinoline-1-sulfonyl)-benzoic acid | IC50 | 30000.0 [1] |
| 2-Methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol | IC50 | 20000.0 [1] |
| 3-(Naphthalen-2-ylsulfamoyl)benzoic acid | IC50 | 30000.0 [1] |
| 3-(3,4-Dihydro-1H-isoquinolin-2-ylsulfonyl)-N,N-dimethylbenzamide | IC50 | 30000.0 [1] |
| Morpholin-4-yl[4-(4-nitrophenyl)piperazin-1-yl]methanone | IC50 | 30000.0 [1] |
| 3-[(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-(2,3-Dihydro-indole-1-sulfonyl)-benzoic acid | IC50 | 30000.0 [1] |
| 3-(3,4-Dihydro-1H-isoquinolin-2-ylsulfonyl)benzamide | IC50 | 30000.0 [1] |
| (E)-2-(4-Fluorophenyl)-3-(4-methylsulfonylphenyl)prop-2-enoic acid | IC50 | 44600.0 [1] |
| (E)-3-(4-Methylsulfonylphenyl)-2-phenylprop-2-enoic acid | IC50 | 34400.0 [1] |
| 3-[2-(4-Methoxyphenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[2-(4-Chlorophenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[2-(2-Fluorophenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[2-(3-Chlorophenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 2-(4-Chloroanilino)benzoic acid | IC50 | 410.0 [1] |
| 5-Fluoro-4-hydroxybiphenyl-3-carboxylic acid | Ki | 1.5 [1] |
| 3-[(4-Nitronaphthalen-1-Yl)amino]benzoic Acid | IC50 | 8170.0 [1] |
| (S)-1-(Naphthalene-2-sulfonyl)-piperidine-3-carboxylic acid | IC50 | 3000.0 [1] |
| (R)-1-(Naphthalene-2-sulfonyl)-piperidine-3-carboxylic acid | IC50 | 30000.0 [1] |
| 1-[3-(2-Chlorophenyl)phenyl]sulfonylpiperidine-3-carboxylic acid | IC50 | 30000.0 [1] |
| 1-[4-(3-Phenylphenyl)phenyl]sulfonylpiperidine-3-carboxylic acid | IC50 | 30000.0 [1] |